Liebermann et al. pioneered the quantitative radioimmunoassay for human I-FABP, suggesting its potential as a diagnostic indicator for early intestinal mucosal vulnerability, as seen in NEC [19]. Here, FABP2 is linked to necrotizing enterocolitis.